Quest Partners LLC Purchases 86,939 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quest Partners LLC lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 379.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 109,832 shares of the medical instruments supplier’s stock after purchasing an additional 86,939 shares during the quarter. Quest Partners LLC’s holdings in DENTSPLY SIRONA were worth $2,972,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in XRAY. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in DENTSPLY SIRONA by 44.2% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock worth $4,684,000 after acquiring an additional 43,230 shares in the last quarter. Scientech Research LLC acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $846,000. Seven Eight Capital LP bought a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $1,409,000. Intech Investment Management LLC bought a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $1,202,000. Finally, Lazard Asset Management LLC raised its holdings in DENTSPLY SIRONA by 3.2% during the 1st quarter. Lazard Asset Management LLC now owns 4,080,795 shares of the medical instruments supplier’s stock worth $135,440,000 after buying an additional 126,351 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Ratings Changes

XRAY has been the subject of several research reports. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Evercore ISI dropped their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Robert W. Baird dropped their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Finally, Needham & Company LLC reduced their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $18.28 on Monday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60. The stock’s 50 day moving average price is $23.92 and its two-hundred day moving average price is $25.38.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 earnings per share. Analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.